JVMSX
Price
$29.15
Change
-$0.22 (-0.75%)
Updated
Aug 15 closing price
Net Assets
23.59B
TOTRX
Price
$11.51
Change
-$0.05 (-0.43%)
Updated
Aug 15 closing price
Net Assets
986.33M
Interact to see
Advertisement

JVMSX vs TOTRX

Header iconJVMSX vs TOTRX Comparison
Open Charts JVMSX vs TOTRXBanner chart's image
JHancock Disciplined Value Mid Cap R2
Price$29.15
Change-$0.22 (-0.75%)
VolumeN/A
Net Assets23.59B
Transamerica Mid Cap Value Opps R
Price$11.51
Change-$0.05 (-0.43%)
VolumeN/A
Net Assets986.33M
JVMSX vs TOTRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMSX vs. TOTRX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMSX is a Buy and TOTRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 23.6B vs. TOTRX (986M). TOTRX pays higher dividends than JVMSX: TOTRX (0.86) vs JVMSX (0.41). JVMSX was incepted earlier than TOTRX: JVMSX (13 years) vs TOTRX (8 years). JVMSX (1.26) and TOTRX (1.23) have similar cost to investors . JVMSX (49.00) and TOTRX (48.00) have comparable annual turnover. JVMSX (0) and TOTRX (0) have matching initial minimum investment requirements. JVMSX annual gain was more profitable for investors over the last year : 0.34 vs. TOTRX (-0.74). JVMSX return over 5 years is better than : 48.09 vs. TOTRX (11.74).
JVMSXTOTRXJVMSX / TOTRX
Total Expense Ratio1.251.23102%
Annual Report Gross Expense Ratio1.261.23102%
Fund Existence13 years8 years-
Gain YTD8.7287.070123%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B986M2,394%
Annual Yield % from dividends0.410.8648%
Returns for 1 year0.34-0.74-46%
Returns for 3 years10.96-4.29-256%
Returns for 5 years48.0911.74410%
Returns for 10 years41.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX1.200.18
+17.65%
Lineage Cell Therapeutics
XPRO10.940.10
+0.92%
Expro Group Holdings NV
DHR210.930.71
+0.34%
Danaher Corp
FGEN9.490.01
+0.16%
FibroGen Inc
CFLT17.79-0.06
-0.34%
Confluent